Global Plasma Protein Therapeutics Market Comprehensive Study: Forecasted Market Size And Growth Rate | CSL Behring LLC, Grifols SA, China Biologic Products Holdings Inc., Takeda Pharmaceutical Company Limited

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2594

The Business Research Company offers in-depth market insights through Plasma Protein Therapeutics Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The plasma protein therapeutics market size has grown strongly in recent years. It will grow from $29.66 billion in 2023 to $32.22 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing prevalence of rare diseases, growing aging population, global blood plasma supply, rise in hemophilia cases, improvements in diagnosis, supportive regulatory environment..

The plasma protein therapeutics market size is expected to see strong growth in the next few years. It will grow to $43.85 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to gene therapy advancements, increasing healthcare expenditure, expanded indications, precision medicine approaches, patient access programs.. Major trends in the forecast period include technological innovations, telemedicine adoption, technological advancements in plasma fractionation, development of next-generation therapies, adoption of recombinant therapies, personalized medicine approaches..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=9213&type=smp

Market Segmentation:
The plasma protein therapeutics market covered in this report is segmented -

1) By Product: Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products
2) By Route Of Administration: Intravenous, Subcutaneous
3) By Applications: Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications

Major Driver - Increasing Prevalence Of Autoimmune Disorders To Enhance Market Position
An increasing prevalence of autoimmune disorders is expected to propel the growth of the plasma protein therapeutics market going forward. An autoimmune disorder is a condition that emerges when the body's immune system attacks and destroys healthy body cells. Therapeutic plasma exchange is used to treat autoimmune diseases, which emerge when the body misidentifies a part of itself as foreign and produces proteins (known as autoantibodies) that attack the part of the body that is misidentified. For instance, in September 2021, according to Scientific American, a US-based science magazine, autoimmune diseases affect about 4% of the global population. Therefore, the increasing prevalence of autoimmune disorders is driving the growth of the plasma protein therapeutics market going forward.

Competitive Landscape:
Major companies operating in the plasma protein therapeutics market report are CSL Behring LLC, Grifols SA, China Biologic Products Holdings Inc., Takeda Pharmaceutical Company Limited, Baxter International Inc., Kedrion SpA, Shire plc, LFB SA, Emergent BioSolutions Inc., Reliance Life Sciences Private Limited, ADMA Biologics Inc., Prothya Biosolutions BV, Bio Products Laboratory Ltd., MP Biomedicals LLC, Biotest AG, Taibang Biological Group Co Ltd, Arthrex Inc., Johnson and Johnson, Abeona Therapeutics Inc., Octapharma Plasma Inc., Bayer AG, Bioverativ Inc., Grifols Biologicals Inc., Baxalta US Inc., New York Blood Center, Green Cross Corporation, China National Biotec Group Company Limited, Kamada Ltd., Australian Red Cross Lifeblood .

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

Top Trend - Innovative Products Drive Competition In The Plasma Protein Therapeutics Market
Product innovations are a key trend gaining popularity in the plasma protein therapeutic gaining market. Major companies operating in the plasma protein therapeutic sector are focused on innovative products to gain a competitive advantage in the market. For instance, November 2021, Biognosys, a Switzerland-based biotechnology company, launched an innovative next-Generation blood biomarker discovery solution. The service is intended to assist researchers in deciphering the complexities of the blood proteome and unlocking unbiased discoveries for pharmaceutical and diagnostic development, as well as precision medicine. A unique feature of both solutions is Biognosys' Hyper Reaction Monitoring (HRMTM) technology and its optimized Liquid Chromatography-Mass Spectrometry (LC-MS) workflow.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Plasma Protein Therapeutics Market Characteristics
3. Plasma Protein Therapeutics Market Trends And Strategies
4. Plasma Protein Therapeutics Market - Macro Economic Scenario
5. Plasma Protein Therapeutics Market Size And Growth
…..
27. Plasma Protein Therapeutics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.